Swiss stocks - Factors to watch on Feb 14 Reuters Europe's largest biotech company Actelion said it would hike its dividend by 25 percent as investors wait for a U.S. regulatory decision on its new heart and lung drug, Opsumit, which it hopes will cut its dependency on current mainstay Tracleer. For ... |
